CN103893625B - 一种治疗脑膜炎的混合中药 - Google Patents
一种治疗脑膜炎的混合中药 Download PDFInfo
- Publication number
- CN103893625B CN103893625B CN201410156995.0A CN201410156995A CN103893625B CN 103893625 B CN103893625 B CN 103893625B CN 201410156995 A CN201410156995 A CN 201410156995A CN 103893625 B CN103893625 B CN 103893625B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- grams
- meningitic
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 241000628997 Flos Species 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 230000036461 convulsion Effects 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000001771 impaired effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 210000003792 cranial nerve Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- 201000009906 Meningitis Diseases 0.000 description 20
- 230000003115 biocidal effect Effects 0.000 description 11
- 230000000840 anti-viral effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001638 cerebellum Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002418 meninge Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- -1 phenethyl alcohol glycosides Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000006081 Cryptococcal meningitis Diseases 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010027209 Meningitis cryptococcal Diseases 0.000 description 1
- 206010027241 Meningitis haemophilus Diseases 0.000 description 1
- 206010027259 Meningitis tuberculous Diseases 0.000 description 1
- 206010027260 Meningitis viral Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 208000022971 Tuberculous meningitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 208000001223 meningeal tuberculosis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000010044 viral meningitis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗脑膜炎的混合中药是按下面的各中药成分和质量比组合而成：黄芩10份、金银花10份、黄连2份、太子参10份、连翘10份、生薏仁10份、决明子10份、蒲公英10份、黄精10份、羚羊角1.5份、甘草5份。一种治疗脑膜炎的混合中药以清凉解毒、抑菌灭菌的中药为主，同时还混合了益气护正之滋补中药太子参以增强人的各器官的生理功能、免疫能力，同时也加进了能麻醉、缓解因脑神经中枢受损所引起的惊痫抽搐的特效珍贵药材羚羊角。
Description
技术领域
本发明涉及的是一治疗脑膜炎的多种中药组成的配方混合药，属于中医学技术领域。
背景技术
脑膜炎是人的脑膜或脑脊膜被细菌或病毒感染攻击所表现出来的病症，由于大脑、小脑、脊髓是人的神经中枢，大脑或小脑的病变会波及到人的身体的各种生理功能，引起人身体的各种功能病症，人的语言、思维、肢体活动功能都可能产生不正常的病理症状。由于脑膜炎是一种细菌性或病毒性的病症，所以脑膜炎是一种传染性的症病，对脑膜炎患者应尽快隔离治疗。引起脑膜炎的细菌或病毒有不同的类型，人们把脑膜炎分作不同的类型，有细菌性脑膜炎、病毒性脑膜炎、结核性脑膜炎、隐球菌性脑膜炎、急性化脓性脑膜炎、流感杆菌脑膜炎。有的脑膜炎病菌或离毒感染人体后能在十几个小时内快速发作，致人死亡，所以一旦发现确诊脑膜炎应尽快治疗。
脑膜炎患者疗应以隔离式的安全治疗，治疗方式也应以中西医结合治疗，对于急性发作的的脑膜炎患者应尽快使用抗生素，但脑膜炎有病毒性，抗生素对病毒性不起作用，所以治疗时也应加入抗病毒的药物，一些亲密接触过脑膜炎患者的人也应进行预防性的抗生素和抗毒性药物的注射。但是，大量的抗生素使用也对人的大脑造成一定的伤害，经常性的抗生素和抗病毒药物的使用也使人的免疫力变得低下，有的患者一旦停止注射抗生素，很快又重新感染。中医中药治疗脑膜炎相比抗生素和抗病毒的西药显效较慢，但很多中药也有很好的灭菌和抗病毒性，并且使用中药疗效较为稳定和安全，不会产生抗生素的过敏危险、大脑伤害、免疫力低下的缺点。
发明内容
为了克服抗生素和抗病毒性西药治疗脑膜炎对患者产生的过敏性、伤害性、削弱人的免疫力的缺点，我们在使用抗生素和抗病毒性西药控制紧急危险症状后合理地使用中医中药进行治疗。中医中药治疗脑膜炎以灭菌解毒、清热开窍、补气护正为辩证施治方案。
一种治疗脑膜炎的混合中药采取的技术方案是按下面的各中药质量比组成：黄芩10份、金银花10份、黄连2份、太子参10份、连翘10份、薏苡仁10份、决明子10份、蒲公英10份、黄精10份、羚羊角1.5份、甘草5份。
一咱治疗脑膜炎的混合中药中的各中药的药性和药理分析：黄芩和金银花能清热燥湿、泻火解毒、抑菌灭菌，黄芩用于治疗脑膜炎主要在于其抗菌功能，黄芩和金银花对痢疾杆菌、副伤寒杆菌、霍乱弧菌、大肠杆菌、变形杆菌等有很好的抑制和消灭作用，黄芩对很多真菌类也能用很好的抑制作用；黄连、也是清热、泻火、解毒、抑菌的中药，黄连应用于脑膜炎也主要是其清热抑菌的功能，能抗细菌、抗真菌、抗病毒，但黄连药味大苦大寒，不宜多服；太子参是一种滋补的中药，太子参中含有大量有益人体的营养物质，其中含有的微量元素铁、铜、锌、镁等，还含有多种的氨基酸、糖类、苷类、磷脂类、环肽类、脂肪酸类、醇类等营养物质，太子参应用于治疗脑膜炎主要是以其能补气生精、增强人的生命力、增强人的各种生理器官的生理机能、增强人的抗病力、增强人的免疫力，太子参的滋补温性也在混合药物中担当起平衡其它清热解毒药物过于寒性的作用；中药连翘中主要含苯乙醇苷类、挥发油类化合物，这些化合物有抗菌、消炎、镇痛、解热、抗病毒、降血压的功效，治疗脑膜炎的很好的疗效；薏苡仁有健脾、补肺、清热、利湿功效，薏苡仁也有一定的抑菌性和灭杀寄生虫的功效；决明子有清肝火、益肾明目、也用于头晕目眩，决明子的能明目止眩是因为其有很大的抗菌性和抗病毒性性；蒲公英是一种清热解毒、抗菌的中药，蒲公英中含有蒲公英素、蒲公英醇、胆碱、有机酸、菊糖等多种健康营养成分，有利尿、退黄疸、利胆等功效；中药黄精有降血压、降血脂、防止动脉硬化、廷缓衰老、抗菌、补气养阴、益肾等功效，黄精中的黄精多糖有免疫激活作用；中药羚羊角中含有磷酸钙、角蛋白质、多种氨基酸、微量无素、无机盐等成分，其中含角蛋白量较多，羚羊角中含有对神经中枢麻醉缓解的物质成分，能止因神经中枢受损、病变而引起的惊痫抽搐，是治疗脑膜炎发作的良药；甘草主要用于调和各中药药性的作用。
一种治疗脑膜炎的混合中药的有益效果是：一种治疗脑膜炎的混合中药利用多味有清热解毒、抗菌抑菌、抗病毒的中药，也利用了能增强人的生命力和免疫力的中药太子参，也利用了能缓解由于脑膜炎发作损伤中区神经系统而产生的惊痫抽搐的药物羚羊角，理论辩证正确、施治全面、疗效显著。
具体实施方式
一种治疗脑膜炎的混合中药的一个人一天所服用的一个剂量是按下面的各中药质量比配合而成：黄芩10克、金银花10克、黄连2克、太子参10克、连翘10克、薏苡仁10克、决明子10克、蒲公英10克、黄精10克、羚羊角1.5克、甘草5克。
一种治疗脑膜炎的混合药物的一般制作使用方法：一.将药黄芩10克、金银花10克、黄连2克、太子参10克、连翘10克、薏苡仁10克、决明子10克、蒲公英10克、黄精10克、甘草5克用水浸润后和干净淡水2升煎煮30分钟得到混合药液约1—1.3升；二、将药渣和液液分离后凉低药液温度分一天三次服完；二.将羚羊角（羚羊角可以是人工繁殖饲养的羚羊头上的角）一小块用小刀人工快速刮刨出1.5克的粉沫平分作二份；三.在服用第一步骤得到的药液时同时将羚羊角粉沫直接吞服，分早晚两次吞服完。
一种治疗脑膜炎的混合药物的紧急制作使用方法：一.将黄芩约10克、金银花约10克、黄连约2克、太子参约10克、连翘10克、薏苡仁约10克、决明子约10克、蒲公英约10克、黄精约10克、甘草约5克直接和热开水（或热水）约1.5升—2升混合煎煮3钟—10分钟得到药液；二.将煎煮得到的药液倒出约0.3升用金属容器进行冷水表面快速降温至可服用的温度；三.在煎煮药液的同时将一小块羚羊角用小刀人工快速刮刨出约1克粉沫；四.将刮刨得的羚羊角粉沫直接放进嘴吞服并同时喝完第三步骤降温了的药液。紧急制作使用方法的几个步骤从取药、煎煮到服用最快可以在5分钟内完成。
Claims (2)
1.一种治疗脑膜炎的混合中药，其特征是按下面各中药的成分和质量比组成：黄芩10份、金银花10份、黄连2份、太子参10份、连翘10份、薏苡仁10份、决明子10份、蒲公英10份、黄精10份、羚羊角1.5份、甘草5份。
2.根据权利要求1所述的一种治疗脑膜炎的混合中药，其特征是一个人一天所服用的一个剂量是按下面的各中药和质量比组成：黄芩10克、金银花10克、黄连2克、太子参10克、连翘10克、薏苡仁10克、决明子10克、蒲公英10克、黄精10克、羚羊角1.5克、甘草5克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410156995.0A CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410156995.0A CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103893625A CN103893625A (zh) | 2014-07-02 |
| CN103893625B true CN103893625B (zh) | 2016-06-29 |
Family
ID=50985409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410156995.0A Active CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103893625B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189644A (zh) * | 2014-09-14 | 2014-12-10 | 洪满 | 治疗化脓性脑膜炎的组合中药 |
| CN107233503A (zh) * | 2017-06-06 | 2017-10-10 | 郜宪林 | 一种缓解脑膜炎的中药组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101601830A (zh) * | 2009-07-10 | 2009-12-16 | 卢速江 | 一种治疗感冒的中药制剂及其制备方法 |
| CN102205058A (zh) * | 2011-05-03 | 2011-10-05 | 曹建华 | 一种治疗惊厥型小儿流行性感冒的中药制备方法 |
| CN103341038A (zh) * | 2013-07-22 | 2013-10-09 | 王兰美 | 一种治疗鸡新城疫、禽流行性感冒的中药配方 |
-
2014
- 2014-04-18 CN CN201410156995.0A patent/CN103893625B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101601830A (zh) * | 2009-07-10 | 2009-12-16 | 卢速江 | 一种治疗感冒的中药制剂及其制备方法 |
| CN102205058A (zh) * | 2011-05-03 | 2011-10-05 | 曹建华 | 一种治疗惊厥型小儿流行性感冒的中药制备方法 |
| CN103341038A (zh) * | 2013-07-22 | 2013-10-09 | 王兰美 | 一种治疗鸡新城疫、禽流行性感冒的中药配方 |
Non-Patent Citations (1)
| Title |
|---|
| 清瘟败毒饮治疗急重症3例;黎志远;《江西中医药》;19891231(第06期);20－21 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103893625A (zh) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758487A (zh) | 一种治疗剥脱性唇炎的中药组合物 | |
| CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
| CN103610885B (zh) | 一种治疗皮疹的中药制剂 | |
| CN103893625B (zh) | 一种治疗脑膜炎的混合中药 | |
| CN104474104A (zh) | 一种防治鸡传染性鼻炎的中药组合物及其制备方法 | |
| CN103495145A (zh) | 一种中药百草足浴粉 | |
| CN103520690B (zh) | 一种舒筋通络降压浴足粉 | |
| CN103623247A (zh) | 一种治疗眩晕症的药物 | |
| CN103610964A (zh) | 一种治疗复发性口腔溃疡的药物 | |
| CN101637558B (zh) | 一种治疗血小板减少性紫癜的药物 | |
| CN104189644A (zh) | 治疗化脓性脑膜炎的组合中药 | |
| CN104606471A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN104758588A (zh) | 一种治疗眩晕的中药组合物 | |
| CN104147295A (zh) | 一种治腹泻的中药药剂 | |
| CN103356779A (zh) | 一种预防及治疗抽筋的药酒 | |
| CN101224295A (zh) | 一种治疗消化系统肿瘤的中药组合物及其制备方法 | |
| CN105770115A (zh) | 一种治疗湿疹的中药药膏 | |
| CN105079661A (zh) | 一种治疗便血的中药组合物 | |
| CN105079514A (zh) | 一种治疗眩晕的中药组合物 | |
| CN105169324A (zh) | 防治风寒感冒的中药制剂 | |
| CN104644868A (zh) | 一种治疗由风湿热引起的关节炎的中药组合物及其制法 | |
| CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 | |
| CN104068283A (zh) | 用于防治绵羊痘的饲料、中药组合物、制备方法及应用 | |
| CN103860960A (zh) | 一种治疗乳腺癌的胶囊及其制备方法 | |
| CN104491823A (zh) | 一种治疗痛经的中药冲剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 536000 the Guangxi Zhuang Autonomous Region Beihai city Chongqing road at Garden Building 2 unit A 402 mailbox Applicant after: Zhang Wenyan Address before: 535000, C2BB402, two, Bailey, Qinzhou, the Guangxi Zhuang Autonomous Region Applicant before: Zhang Wenyan |
|
| COR | Change of bibliographic data | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 535400 Qinzhou County, Lingshan City, the Guangxi Zhuang Autonomous Region, six Peak Road, Lingshan county science and technology information Patentee after: Zhang Wenyan Address before: 536000 the Guangxi Zhuang Autonomous Region Beihai city Chongqing road at Garden Building 2 unit A 402 mailbox Patentee before: Zhang Wenyan |
|
| CP02 | Change in the address of a patent holder | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190226 Address after: 233010 409 Wu Wan Road, Yuhui District, Bengbu, Anhui Patentee after: BENGBU JINSHI NEW MATERIAL Co.,Ltd. Address before: 230031 B-1014, 10 floor, business office building, Wo Ye garden, Shushan District, Hefei, Anhui. Patentee before: HEFEI WISDOM LOTUT INTELLECTUAL PROPERTY Co.,Ltd. Effective date of registration: 20190226 Address after: 230031 B-1014, 10 floor, business office building, Wo Ye garden, Shushan District, Hefei, Anhui. Patentee after: HEFEI WISDOM LOTUT INTELLECTUAL PROPERTY Co.,Ltd. Address before: 535400 Lingshan Science and Technology Information Institute, Liufeng Road, Lingshan County, Lingshan County, Qinzhou City, Guangxi Zhuang Autonomous Region Patentee before: Zhang Wenyan |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190711 Address after: 230000 B-1512, west of Ganquan Road, Shushan District, Hefei, Anhui. Patentee after: ANHUI YINGLONG INDUSTRIAL DESIGN Co.,Ltd. Address before: 233010 409 Wu Wan Road, Yuhui District, Bengbu, Anhui Patentee before: BENGBU JINSHI NEW MATERIAL Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20191114 Address after: 363200, Zhangzhou, Fujian province Zhangpu Sui An Industrial Zone Patentee after: TONGYITANG PHARMACEUTICAL Co.,Ltd. Address before: Ganquan road Shushan District of Hefei City, Anhui Province, 230000 West hillock road to the South Wild Garden commercial office building room B-1512 Patentee before: ANHUI YINGLONG INDUSTRIAL DESIGN Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A mixed traditional Chinese medicine for treating meningitis Effective date of registration: 20231231 Granted publication date: 20160629 Pledgee: Bank of China Limited by Share Ltd. Zhangpu branch Pledgor: TONGYITANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980075812 |